Insider Selling: Rapid Micro Biosystems (NASDAQ:RPID) Major Shareholder Sells $190,120.00 in Stock

Rapid Micro Biosystems, Inc. (NASDAQ:RPID) major shareholder Longitude Capital Partners Ii, sold 49,000 shares of the company’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $3.88, for a total transaction of $190,120.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

Longitude Capital Partners Ii, also recently made the following trade(s):

• On Monday, February 2nd, Longitude Capital Partners Ii, sold 27,500 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.25, for a total transaction of $116,875.00.
• On Friday, January 30th, Longitude Capital Partners Ii, sold 46,000 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.54, for a total value of $208,840.00.
• On Friday, January 23rd, Longitude Capital Partners Ii, sold 7,739 shares of Rapid Micro Biosystems stock. The shares were sold at an average price of $4.06, for a total value of $31,420.34.

Rapid Micro Biosystems Stock Performance

Shares of RPID opened at $3.87 on Monday. The company has a 50-day moving average of $3.67 and a two-hundred day moving average of $3.40. The stock has a market cap of $171.52 million, a P/E ratio of -3.83 and a beta of 1.38. Rapid Micro Biosystems, Inc. has a 12-month low of $1.86 and a 12-month high of $4.94. The company has a current ratio of 4.23, a quick ratio of 2.95 and a debt-to-equity ratio of 0.42.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its earnings results on Friday, November 7th. The company reported ($0.26) EPS for the quarter, meeting analysts’ consensus estimates of ($0.26). The firm had revenue of $7.84 million for the quarter, compared to analysts’ expectations of $7.60 million. Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%. As a group, research analysts predict that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on RPID. Wall Street Zen downgraded Rapid Micro Biosystems from a “hold” rating to a “sell” rating in a research report on Saturday, January 17th. Weiss Ratings reissued a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Thursday, January 22nd. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Rapid Micro Biosystems presently has a consensus rating of “Moderate Buy” and an average target price of $8.00.

Hedge Funds Weigh In On Rapid Micro Biosystems

Institutional investors have recently modified their holdings of the company. Geode Capital Management LLC boosted its position in Rapid Micro Biosystems by 1.6% during the 2nd quarter. Geode Capital Management LLC now owns 204,079 shares of the company’s stock worth $704,000 after acquiring an additional 3,143 shares during the period. American Century Companies Inc. grew its stake in shares of Rapid Micro Biosystems by 46.1% in the 2nd quarter. American Century Companies Inc. now owns 16,922 shares of the company’s stock worth $58,000 after purchasing an additional 5,341 shares during the last quarter. Susquehanna International Group LLP grew its position in Rapid Micro Biosystems by 12.6% in the third quarter. Susquehanna International Group LLP now owns 58,387 shares of the company’s stock worth $195,000 after buying an additional 6,528 shares during the last quarter. Hudson Bay Capital Management LP acquired a new position in shares of Rapid Micro Biosystems in the 3rd quarter worth $38,000. Finally, Dimensional Fund Advisors LP increased its stake in Rapid Micro Biosystems by 37.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after purchasing an additional 15,255 shares in the last quarter. Institutional investors own 52.60% of the company’s stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.